Apple Prevails in Trade Tribunal Over Masimo's Blood-Oxygen Patent Dispute

Apr 18, 2026

1 minute read

The U.S. International Trade Commission ruled for Apple against Masimo's bid to reinstate an import ban on Apple Watches. The ITC declined to review a judge's March ruling that Apple's redesigned watches don't infringe Masimo's blood-oxygen patents. Masimo can appeal to the Federal Circuit. The dispute stems from Masimo's accusations that Apple stole pulse-oximetry technology. Apple previously removed blood-oxygen features to avoid a December 2023 import ban, then reintroduced updated technology.

Read the full story on Republicworld

Stay informed!

Subscribe to receive weekly litigation news updates. No spam.